CISATRACURIUM BESYLATE

Post-LOE

cisatracurium besylate

ANDAINJECTIONINJECTABLE
Approved
Nov 2020
Lifecycle
Post-LOE
Competitive Pressure
30/100

Mechanism of Action

end-plate to antagonize the action of acetylcholine, resulting in blockade of neuromuscular transmission. This action is antagonized by acetylcholinesterase inhibitors such as neostigmine.